Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent inhaled nitric oxide dose-finding study in hospitalized infants with acute bronchiolitis
MOH_2019-08-13_007341Phase 2Completed
- Sponsor
- Beyond Air
- Start
- Jul 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitric oxide in bronchiolitis (3 arms), sponsored by Beyond Air. Primary endpoint: Time to readiness for discharge. Started Jul 2019; status: completed.
02
Drugs
nitric oxide
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on MOH_2019-08-13_007341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-08-13_007341.